Vascular Diseases  >>  cilostazol  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cilostazol / Generic mfg.
NCT00602173: Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting Conditions

Completed
N/A
32
US
Cilostazol
Roxane Laboratories
Intermittent Claudication
05/03
05/03
NCT00602407: Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions

Completed
N/A
36
US
Cilostazol
Roxane Laboratories
Intermittent Claudication
03/04
03/04
NCT00216749: Efficacy and Safety of Cilostazol for the Indication of CSPS

Completed
N/A
650
RoW
Korea Otsuka Pharmaceutical Co., Ltd.
Cerebral Infarction
10/07
10/07
NCT01779401: Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients

Completed
N/A
1078
RoW
Clopidogrel 75mg, Clopidogrel 150mg, Aspirin 100mg, Cilostazol 100mg
Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing Municipal Health Bureau, Haemonetics Corporation, Zhejiang Otsuka Pharmaceutical Co., Ltd.
Coronary Heart Disease
09/16
09/16

Download Options